{"id":"https://openalex.org/W1926317532","doi":"https://doi.org/10.1016/s0022-3565(24)36800-4","title":"In Vitro and In Vivo Characterization of the Dopamine D4 Receptor, Serotonin 5-HT2AReceptor and Alpha-1 Adrenoceptor Antagonist (R)-(+)-2-Amino-4-(4-Fluorophenyl)- 5-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Pyrrolidin-3-yl]Thiazole (NRA0045)","display_name":"In Vitro and In Vivo Characterization of the Dopamine D4 Receptor, Serotonin 5-HT2AReceptor and Alpha-1 Adrenoceptor Antagonist (R)-(+)-2-Amino-4-(4-Fluorophenyl)- 5-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Pyrrolidin-3-yl]Thiazole (NRA0045)","publication_year":1997,"publication_date":"1997-07-01","ids":{"openalex":"https://openalex.org/W1926317532","doi":"https://doi.org/10.1016/s0022-3565(24)36800-4","mag":"1926317532","pmid":"https://pubmed.ncbi.nlm.nih.gov/9223539"},"language":"en","primary_location":{"id":"doi:10.1016/s0022-3565(24)36800-4","doi":"https://doi.org/10.1016/s0022-3565(24)36800-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)36800-4","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110113221","display_name":"Shigeru Okuyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shigeru Okuyama","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","1st Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]},{"raw_affiliation_string":"1st Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., Ohmiya, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039021133","display_name":"Shigeyuki Chaki","orcid":"https://orcid.org/0000-0003-4444-2911","observed_orcids":["https://orcid.org/0000-0003-4444-2911","https://orcid.org/0000-0001-5608-4192"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeyuki Chaki","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111700681","display_name":"Ryoko Yoshikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryoko Yoshikawa","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103702714","display_name":"Yoshiko Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiko Suzuki","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109316203","display_name":"Shinichi Ogawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin-Ichi Ogawa","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047573124","display_name":"Yasuko Imagawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuko Imagawa","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110697914","display_name":"Naoya Kawashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoya Kawashima","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yoko Ikeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoko Ikeda","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112582808","display_name":"Toshihito Kumagai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshihito Kumagai","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113554239","display_name":"Atsuro Nakazato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsuro Nakazato","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075625024","display_name":"Masashi Nagamine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masashi Nagamine","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089010280","display_name":"Kazuyuki Tomisawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4210134850","display_name":"Nihon Nohyaku (Japan)","ror":"https://ror.org/02s7nat60","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210134850"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuyuki Tomisawa","raw_affiliation_strings":["1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1st Laboratory (S.O., S.C., R.Y., Y.S., S.O., Y.I., N.K., T.K., N.A., K.T.) and Molecular Biology Laboratory (Y.I.), Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiya, Saitama 330, Japan and Research Center (M.N.), Nihon Nouyaku Co., Ltd., Kawachi-Nagano, Osaka 586, Japan","institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110113221"],"corresponding_institution_ids":["https://openalex.org/I144245601","https://openalex.org/I4210134850"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.7938,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.67411721,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"282","issue":"1","first_page":"56","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6050000190734863,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.6050000190734863,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.35280001163482666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d4-receptor","display_name":"dopamine D4 receptor","score":0.8190000057220459},{"id":"https://openalex.org/keywords/5-ht2a-receptor","display_name":"5-HT2A receptor","score":0.9829999804496765},{"id":"https://openalex.org/keywords/alpha1-adrenergic-receptors","display_name":"alpha1-adrenoceptors","score":0.8679999709129333},{"id":"https://openalex.org/keywords/thiazole-derivatives","display_name":"thiazole derivatives","score":0.8259999752044678},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.5789999961853027},{"id":"https://openalex.org/keywords/stereotyped-behavior","display_name":"stereotypy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antipsychotic-activity","display_name":"antipsychotic activity","score":0.621999979019165},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.5109999775886536},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.44999998807907104},{"id":"https://openalex.org/keywords/in-vivo-pharmacology","display_name":"in vivo pharmacology","score":0.44699999690055847},{"id":"https://openalex.org/keywords/in-vitro-pharmacology","display_name":"in vitro pharmacology","score":0.5529999732971191}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5872107148170471},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5616829991340637},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.538755476474762},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5206098556518555},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4783153831958771},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.45811858773231506},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4332352578639984},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4290352463722229},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2734163701534271},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17511805891990662},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12214314937591553}],"mesh":[{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002375","descriptor_name":"Catalepsy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013239","descriptor_name":"Stereotyped Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019556","descriptor_name":"COS Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044402","descriptor_name":"Receptor, Serotonin, 5-HT2A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050638","descriptor_name":"Receptors, Dopamine D4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058668","descriptor_name":"Adrenergic alpha-1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D065127","descriptor_name":"Dopamine D2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0022-3565(24)36800-4","doi":"https://doi.org/10.1016/s0022-3565(24)36800-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)36800-4","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:9223539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9223539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"mag:1926317532","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9223539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W14947124","https://openalex.org/W1556416492","https://openalex.org/W1766643663","https://openalex.org/W1775749144","https://openalex.org/W1809659791","https://openalex.org/W1954888178","https://openalex.org/W1964936180","https://openalex.org/W1965505200","https://openalex.org/W1966092598","https://openalex.org/W1971290197","https://openalex.org/W1977120421","https://openalex.org/W1979258932","https://openalex.org/W1984895766","https://openalex.org/W1985582613","https://openalex.org/W1987807082","https://openalex.org/W1994065699","https://openalex.org/W1996137477","https://openalex.org/W2007980582","https://openalex.org/W2013593246","https://openalex.org/W2021784043","https://openalex.org/W2022151784","https://openalex.org/W2030121284","https://openalex.org/W2030635333","https://openalex.org/W2033428309","https://openalex.org/W2034269648","https://openalex.org/W2042145943","https://openalex.org/W2046291435","https://openalex.org/W2047313629","https://openalex.org/W2050563394","https://openalex.org/W2053173214","https://openalex.org/W2058878704","https://openalex.org/W2059230444","https://openalex.org/W2070950079","https://openalex.org/W2072069319","https://openalex.org/W2074631079","https://openalex.org/W2075028631","https://openalex.org/W2079552625","https://openalex.org/W2091190659","https://openalex.org/W2095148556","https://openalex.org/W2106410122","https://openalex.org/W2134812217","https://openalex.org/W2151303352","https://openalex.org/W2165075766","https://openalex.org/W2243263130","https://openalex.org/W2416785656","https://openalex.org/W2476290501","https://openalex.org/W2802313649","https://openalex.org/W2949936188","https://openalex.org/W4285719527","https://openalex.org/W6600631562","https://openalex.org/W6637947583","https://openalex.org/W6655725225","https://openalex.org/W6720935808"],"related_works":["https://openalex.org/W2094247576","https://openalex.org/W4237273841","https://openalex.org/W3106125286","https://openalex.org/W3101010085","https://openalex.org/W3098660955","https://openalex.org/W2168219387","https://openalex.org/W1987800591","https://openalex.org/W2068527494","https://openalex.org/W2009395513","https://openalex.org/W2137156824"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}